LOUISVILLE, Ky., Nov. 21, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that Company management will participate at two upcoming virtual investor conferences. BTIG Virtual Digital Health Forum Panel on Monday, November 25th at 9:00AM ET Bank of America Virtual Home Care Conference 2024Fireside Chat on Tuesday, December 10th at 2:10PM ET A live and archived webcast of the Bank of America Home Care Conference Fireside Chat will be available on the "Event & Presentations" section of the BrightSpring investor relations website at https://ir.brightspringhealth.com/. About BrightSpring Health Services Brig

LOUISVILLE, Ky., Nov. 06, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "BrightSpring Health Services") (NASDAQ:BTSG) is proud that CareMed, a BrightSpring company and leading independent Specialty Pharmacy, was selected by Eisai to be the national specialty pharmacy provider for Leqembi®, a cutting-edge treatment for Alzheimer's disease. "We're proud of the work CareMed is doing with manufacturers and prescribers to improve and extend the lives of patients living with mild cognitive impairment and dementia, bringing more treatment options to Alzheimer's disease," said BrightSpring's President and CEO, Jon Rousseau. "CareMed's partnership with Eisai shows their

LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the third quarter ended September 30, 2024, and increases 2024 revenue and Adjusted EBITDA1 guidance. Financial Highlights Net Revenue of $2,907 million, up 28.8% compared to $2,257 million in the third quarter of 2023.Net loss of $9.0 million, compared to net loss of $130.1 million in the third quarter of 2023.Adjusted EBITDA1 of $151 million, up 15.7% versus $131 million in the third quarter of 2023Increased 2024 Revenue and Adju

LOUISVILLE, Ky., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its third quarter 2024 financial results on Friday, November 1, 2024, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference

LOUISVILLE, Ky., Sept. 30, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home- and community-based health services for complex populations, today announced that Dr. Steve Miller was appointed as a Class II member of the Board of Directors. Dr. Miller will also serve as a member of the Board's Audit Committee and as the chair of the Board's Quality & Compliance and Governance Committee. As a nationally recognized advocate for greater access, affordability, and excellence in healthcare, Dr. Miller brings decades of experience to the Company as a medical researcher, clinician, and administrator across numerous hea

LOUISVILLE, Ky., Sept. 13, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that investment funds managed by KKR & Co. Inc. and its subsidiaries ("KKR"), an existing shareholder of BrightSpring, have entered into an agreement with Walgreen Co. ("WBA") to purchase 11,619,998 shares of BrightSpring's common stock from WBA in a private transaction. The transaction was negotiated directly between KKR and WBA, with KKR making the investment through its private equity funds. BrightSpring is not issuing or selling any shares of common stock

PITTSBURGH, Sept. 12, 2024 /PRNewswire/ -- North Central Florida Hospice, Inc. and Haven Medical Group, LLC (collectively "Haven Hospice"), a Florida-based company for comprehensive hospice care services in 18 counties in north central Florida completed its sale of select assets to BrightSpring Health Services (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, effective September 1, 2024. Haven Hospice's Mission remains unchanged: "Honoring life by providing comfort, care and compassion to individuals and families we serve." In a separate but related transaction, BrightSpring also acquired the Attic Resale Stores.

LOUISVILLE, Ky., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that it completed the acquisition of the assets of North Central Florida Hospice, Inc. and Haven Medical Group, LLC (collectively "Haven Hospice"), a Florida-based company holding a Certificate of Need (CON) for comprehensive hospice care services in 18 counties in north central Florida, effective September 1, 2024. "We are excited to welcome Haven Hospice into BrightSpring, expanding our existing hospice services into the CON state of Florida," said Bright

LOUISVILLE, Ky., Aug. 22, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that the Company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference. Company management will present on Friday, September 6th at 12:20pm ET. A live and archived webcast of the event will be available on the "Event & Presentations" section of the BrightSpring investor relations website at https://ir.brightspringhealth.com/. About BrightSpring Health ServicesBrightSpring Health Services is the parent company of leading service lines that provide integrated home- and community-based pharmacy and health solutions fo

LOUISVILLE, Ky., Aug. 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the second quarter ended June 30, 2024, and increases 2024 revenue and Adjusted EBITDA1 guidance. Financial Highlights Net Revenue of $2,730 million, up 26.0% compared to $2,167 million in the second quarter of 2023.Net income of $19.4 million, compared to net income of $2.8 million in the second quarter of 2023.Adjusted EBITDA1 of $139 million, down 6.9% versus $149 million in the second quarter of 2023 When excluding a certain $3

LOUISVILLE, Ky., Sept. 30, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home- and community-based health services for complex populations, today announced that Dr. Steve Miller was appointed as a Class II member of the Board of Directors. Dr. Miller will also serve as a member of the Board's Audit Committee and as the chair of the Board's Quality & Compliance and Governance Committee. As a nationally recognized advocate for greater access, affordability, and excellence in healthcare, Dr. Miller brings decades of experience to the Company as a medical researcher, clinician, and administrator across numerous hea

LOUISVILLE, Ky., April 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that on April 24, 2024, BrightSpring appointed Timothy A. Wicks as a new member of the Board of Directors. Mr. Wicks will assume his new role effective immediately, bringing the Company's total Board of Directors to seven members, including two independent directors. Mr. Wicks brings over 20 years of executive leadership experience in the healthcare industry to BrightSpring's Board of Directors, including his most recent role as Executive Vice President

8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)

10-Q - BrightSpring Health Services, Inc. (0001865782) (Filer)

8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)

8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)

8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)

D - BrightSpring Health Services, Inc. (0001865782) (Filer)

10-Q - BrightSpring Health Services, Inc. (0001865782) (Filer)

8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)

8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)

8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)

The company announced a definitive agreement to acquire the assets of North Central Florida Hospice, Inc. and Haven Medical Group, LLC (collectively "Haven Hospice"), a Florida-based company holding a Certificate of Need (CON) for comprehensive hospice care services in 18 counties in north central Florida. otal consideration for the acquisition is $60 million, with $15 million in cash at close, $30 million in Company equity at close, and an additional $15 million in a seller note payable four years after closing.

BTIG analyst David Larsen initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a Buy rating and announces Price Target of $15.

Analysts' ratings for BrightSpring Health (NASDAQ:BTSG) over the last quarter vary from bullish to bearish, as provided by 11 analysts. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 6 4 1 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 6 3 1 0 0 Analysts have set 12-month price targets for BrightSpring Health, revealing an average target of $16.77, a high estimate of $26.00, and a low estimate of $11.50. Observing a downward trend, the current average is 18.2% low

Wells Fargo analyst Stephen Baxter maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $15 to $16.

BrightSpring Health (NASDAQ:BTSG) reported quarterly earnings of $0.12 per share which beat the analyst consensus estimate of $0.07 by 71.43 percent. This is a 220 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $2.577 billion which beat the analyst consensus estimate of $2.313 billion by 11.41 percent. This is a 27.07 percent increase over sales of $2.028 billion the same period last year.

On CNBC's Mad Money Lightning Round,” Jim Cramer said Dynatrace, Inc. (NYSE:DT) is “very expensive” stock, and he is not going to recommend it. On April 19, TD Cowen analyst Andrew Sherman maintained Dynatrace with a Buy and lowered the price target from $62 to $58. Canopy Growth Corporation (NASDAQ:CGC) is the “best of the pot stocks,” Cramer said, “We don't think it's worth all that much, but we do think it's the best of that lot.” On April 18, Canopy Growth announced that CBI exchanged 17,149,925 common shares in the capital of the company for exchangeable shares for no consideration When asked about BrightSpring Health Services, Inc. (NASDAQ:BTSG), he said, “That short positi

BrightSpring Health Services ("BrightSpring" or "BrightSpring Health Services") (NASDAQ:BTSG) announced today that its company Onco360®, a leading independent oncology pharmacy, was selected as a national pharmacy partner by Alexion Pharmaceuticals for a first-in-class, oral, Factor D inhibitor, Voydeya® (Danicopan) to treat patients with a rare, life-threatening disease of the blood called paroxysmal nocturnal hemoglobinuria (PNH) who are experiencing extravascular hemolysis (EVH). Voydeya® is FDA-approved as add-on therapy to Ultomiris® (Ravulizumab) or Soliris® (Eculizumab) for patients living with PNH that experience continued anemia, or EVH. This innovative drug will complement current

HSBC analyst Sidharth Sahoo initiates coverage on BrightSpring Health (NASDAQ:BTSG) with a Buy rating and announces Price Target of $13.